2. Academic Validation
  3. Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa

  • Bioorg Med Chem Lett. 2004 Dec 6;14(23):5817-22. doi: 10.1016/j.bmcl.2004.09.043.
Werner W K R Mederski 1,  Bertram Cezanne,  Christoph van Amsterdam,  Karl-Ulrich Bühring,  Dieter Dorsch,  Johannes Gleitz,  Joachim März,  Christos Tsaklakidis
Affiliations

Affiliation

  • 1 Merck KGaA, Preclinical Pharmaceutical Research, 64271 Darmstadt, Germany. [email protected]
PMID: 15501047 DOI: 10.1016/j.bmcl.2004.09.043
Abstract

Neutral chlorothiophenecarboxamides bearing an amino acid and a substituted aniline were synthesized and investigated for their Factor Xa inhibitory activity in vitro. From selected 2-methylphenyl morpholinones the solution properties were determined. The most soluble and active compounds were then investigated in different animal species to compare the pharmacokinetic parameters. This led to a potent, water soluble and orally bioavailable candidate for further development: EMD 495235.

Figures
Products